Efficacy and tolerability of bevacizumab (BEV) plus capecitabine and cisplatin (XP) in Chinese patients (pts) with locally advanced or metastatic gastric/gastroesophageal junction cancer (AGC): Results from the AVATAR study.
Lin Shen
No relevant relationships to disclose
Jin Li
No relevant relationships to disclose
Jian-Ming Xu
No relevant relationships to disclose
Hong-Ming Pan
No relevant relationships to disclose
Guanghai Dai
No relevant relationships to disclose
Shukui Qin
No relevant relationships to disclose
Liwei Wang
No relevant relationships to disclose
Jinwan Wang
No relevant relationships to disclose
Zhenzhou Yang
No relevant relationships to disclose
Shu Yongqian
No relevant relationships to disclose